Protagonist Therapeutics Announces Resolution of Contract Dispute with Zealand Pharma
- Tuesday, August 10, 2021, 7:10
- Business
- Add a comment
NEWARK, Calif., Aug. 10, 2021 /PRNewswire/ — Protagonist Therapeutics, Inc. (Nasdaq: PTGX) (“Protagonist” or “the Company”) today announced it has resolved its Collaboration Agreement dispute with Zealand Pharma by reducing future development and sales milestone payments and royalties…
About the Author
adminasapcorp has written 41760 stories on this site.